Governor vetoes bill that would have benefited new Franklin cancer center

Gov. Bill Haslam has vetoed a bill that would have aided a cancer treatment center being constructed in Middle Tennessee. The bill, which passed the House by a vote of 82-13 and by a 29-1 vote in the Senate, would have required insurance coverage of proton cancer therapy for state employees. The veto comes as the construction of a $100 million cancer-treatment center by Provision CARES Proton Therapy nears completio n in Franklin. It will be the second center for Knoxville-based Provision CARES,…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news

Related Links:

Org. Biomol. Chem., 2018, Accepted Manuscript DOI: 10.1039/C8OB01526K, PaperQianqian Wang, Xiaoli An, Jiahui Xu, Yuwei Wang, Liang Liu, Lai-Han Leung, Xiaojun Yao Selective modulation of individual bromodomains (BDs) by small molecules represents an important strategy for the treatment of various cancers, considering that the BD-containing proteins share common BD structures and distinct... The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Organic and Biomolecular Chemistry - Category: Molecular Biology Authors: Source Type: research
Dalton Trans., 2018, Accepted Manuscript DOI: 10.1039/C8DT01724G, PaperSrinivasareddy Telukutla, Steven Priv ér, Vijay Venoba Rao, Nedaossadat Mirzadeh, Suresh K. Bhargava A series of gold(I), gold(III) and cationic gold(I) complexes of tris(4-methoxyphenyl)phosphine and tris(2,6-dimethoxyphenyl)phosphine were synthesized and fully characterized by spectroscopic methods. The molecular structures of selected complexes were also determined... The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Dalton Trans. latest articles - Category: Chemistry Authors: Source Type: research
The idea that lifestyle changes have made the disease more common is a gross exaggeration – but increasingly prevalent. We separate fact from fictionCancer is not up there withthe most likely explanations for what caused the mass extinction 66m years ago of the T rex and the triceratops. That said, at leastone species of dinosaur suffered from blood-vessel tumours – anda 1.7m-year-old toe with bone cancer was discovered in 2016 at a South African world heritage site.Cancer may have been more common in ancient times than we will ever know, because fossilisation will have obliterated most evidence of the disease....
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Cancer research Health & wellbeing Society Medical research Science Life and style Source Type: news
While football (soccer) training may be a potent strategy for health promotion in older men, the considerable risk of injuries may constitute a barrier for referral of clinical populations. The current study explored the attitudes of men with prostate canc...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Recreational and Sports Issues Source Type: news
LUNG cancer symptoms usually begin to show as the condition progresses, with no indications in the early stages. But when they do become apparent the most common sign is a cough, particularly one that won ’t go away or gets worse. There are seven symptoms of the disease all together to look out for.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
[Premium Times] A Professor of Pharmacognosy at Obafemi Awolowo University, Joseph Aladesanmi, who invented a yet to be clinically tested anti-cancer drug, has decried poor funding of research in Nigeria.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
Chinese regulators are speeding up drug approvals, with Roche's Alecensa cancer medicine the latest beneficiary in a market that is growing increasingly important for international pharmaceuticals companies' growth plans.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Roche today announced that the China National Drug Administration (CNDA) has granted marketing authorisation for Alecensa ® (alectinib) as a monotherapy treatment for patients with anaplastic lymphoma kinase (ALK)-positive, advanced non-small cell lung cancer (NSCLC).
Source: Roche Media News - Category: Pharmaceuticals Source Type: news
(Elsevier) A report in The Journal of Molecular Diagnostics describes a new assay, anchored multiplex PCR (AMP)-based targeted next-generation-sequencing (NGS), with superior diagnostic utility compared to conventional techniques. This includes the ability to analyze numerous target genes simultaneously and identify new fusion partners. In four cases, the assay diagnosed sarcoma in samples deemed falsely negative by conventional tests.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
(Wiley) A new study provides insights into the degree to which socioeconomic status explains racial and ethnic disparities in childhood cancer survival. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings may inform where to allocate resources to best reduce racial and ethnic survival disparities for each of the major types of childhood cancer.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Therapy | Health Management | Insurance | Pharmaceuticals | Proton Therapy